Jeena Sikho Lifecare Ltd — earnings calls

Jeena Sikho Lifecare reported Q1 FY27 revenue from operations of INR224 crores, EBITDA of INR92 crores and PAT of INR65 crores, with management citing a 41% EBITDA margin and 28% PAT margin. Management said revenue grew 29% year-on-year, supported by higher patient footfalls, service network expansion and continued growth in the products business, while Panchakarma revenue grew 13% on higher IPD and daycare volumes. Management also discussed a reduction in government hospital business, a new ultra-luxury wellness property in Manali, ongoing OTC distribution talks with Entero, and one-off expenses related to advertising and software this quarter.

Jeena Sikho Lifecare reported FY26 revenue from operations of INR801 crores, up 71% year-on-year, with EBITDA of INR349 crores at a 44% margin and PAT of INR222 crores, up 177%. Management attributed Q4 profit softness to one-time items including labour code provisioning, ESOP costs, a leasehold accounting review under new auditor Grant Thornton, and an ECL provision totaling approximately INR21 crores. Management also described plans to expand operational beds from about 2,300 toward 3,000 in the coming months and outlined a target of 7,000 to 10,000 beds over three to five years.